Charlot Biosciences

About:

Helping Release Life Saving Treatments to Patients When They Need it Most!

Top Investors: Leonid Capital Partners

Description:

CBio develops diagnostic test kits using emerging microfluidics techniques and machine vision to identify pathogens in various settings.

Total Funding Amount:

$760000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Tampa, Florida, United States

Founded Date:

2016-10-19

Contact Email:

david(AT)cbio.io

Founders:

David Charlot

Number of Employees:

1-10

Last Funding Date:

2021-11-01

IPO Status:

Private

Industries: